Verona pharma to present additional analyses of phase 3 enhance studies in copd at ers international congress 2024

Verona pharma presents one oral presentation and 3 posters on additional analyses from its successful phase 3 enhance studies with ohtuvayre at ers 2024.

VRNA Ratings Summary

VRNA Quant Ranking